
EssilorLuxottica (EL) | Stock Overview & Key Data
EssilorLuxottica Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €298.00 on February 10, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
EssilorLuxottica EL | 117.98B Large-cap | -3.22% | 6.46% | 3.49% | -6.56% | 7.69% | 20.96% | 54.82% | 129.38% |
Sartorius Stedim DIM | 16.73B Large-cap | -4.77% | -16.28% | -17.44% | -20.76% | -9.45% | -4.23% | -56.05% | -41.28% |
Amplitude Surgical AMPLI | 299.85M Mid-cap | 0.00% | 1.64% | 1.64% | 80.23% | 93.75% | 100.00% | 100.65% | 192.45% |
Crossject S.A ALCJ | 73.36M Small-cap | -14.12% | -17.51% | -6.41% | -22.34% | -34.82% | -21.93% | -66.67% | -63.50% |
Visiomed Group SA ALVMG | 53.17M Small-cap | -5.00% | 5.56% | 5.56% | 0.00% | 11.76% | 11.76% | -47.22% | -80.81% |
Bonyf N.V MLBON | 7.77M Small-cap | 0.00% | 0.00% | -25.86% | -31.38% | -28.33% | -19.88% | 7.50% | 3.20% |
Ownership & Short Interest
EssilorLuxottica Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in EssilorLuxottica would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EL's 52-week high and low?
- In the last 52 weeks, EssilorLuxottica reached a high of €298.00 (on February 14, 2025) and a low of €202.10 (on September 23, 2024).
- What is the market cap and P/E ratio for EL?
- Curious about EssilorLuxottica's size and valuation? Its market capitalization stands at 117.98B. When it comes to valuation, the P/E ratio (trailing twelve months) is 48.88, and the forward P/E (looking ahead) is 32.88.
- Does EL pay dividends? If so, what's the yield?
- Yes, EssilorLuxottica is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.64%, and the company has paid an average of €3.71 per share annually over the past 3 years.
- Who are EssilorLuxottica's main competitors or similar companies to consider before investing?
When looking at EssilorLuxottica, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sartorius Stedim
DIM16.73B Healthcare Medical Instruments & Supplies -4.23% -56.05% Amplitude Surgical
AMPLI299.85M Healthcare Medical Instruments & Supplies 100.00% 100.65% Crossject S.A
ALCJ73.36M Healthcare Medical Instruments & Supplies -21.93% -66.67% Visiomed Group SA
ALVMG53.17M Healthcare Medical Instruments & Supplies 11.76% -47.22% Bonyf N.V
MLBON7.77M Healthcare Medical Instruments & Supplies -19.88% 7.50% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for EssilorLuxottica S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of EssilorLuxottica's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.44%, the Debt to Equity ratio from the most recent quarter is 36.58, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for EL?
- Looking at EssilorLuxottica's growth, its revenue over the trailing twelve months (TTM) was €27B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.50%, and quarterly earnings saw a YoY growth of 1.60%.
- How much of EL stock is held by insiders and institutions?
- Wondering who owns EssilorLuxottica stock? Company insiders (like executives and directors) hold about 36.89% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 29.74%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.